Ipamorelin: Clean Growth Hormone Release
Ipamorelin is a pentapeptide that selectively stimulates growth hormone release from the pituitary gland:
Selective GHS Action: Ipamorelin binds to ghrelin receptors (GHSR) on pituitary somatotroph cells, triggering GH release in clean, physiological pulses. Crucially, it does this without significantly raising cortisol, prolactin, or ACTH — making it the most selective GH secretagogue available.
Pulsatile GH Release: Unlike exogenous GH injection, Ipamorelin triggers the body's own GH production in a pulsatile pattern that mimics natural physiology. This reduces the risk of receptor desensitisation and hormonal disruption.
Research Applications: Body composition optimisation, sleep quality improvement, recovery support, bone density research, and anti-ageing studies. Ipamorelin's selectivity makes it ideal for isolating GH-specific effects from confounding hormonal changes.
ORYN Format: €109 for a 30-day pen containing 6mg of pharmaceutical-grade Ipamorelin with >99% purity.
Tirzepatide: Dual Metabolic Intervention
Tirzepatide is a dual GIP/GLP-1 receptor agonist representing the cutting edge of metabolic peptide science:
Dual Receptor Action: Unlike semaglutide (GLP-1 only), Tirzepatide activates both GIP and GLP-1 receptors. GIP enhances fat metabolism and lipid handling in adipose tissue. GLP-1 controls appetite, insulin release, and gastric emptying. Together, they create a comprehensive metabolic intervention.
Clinical Evidence: SURPASS and SURMOUNT trials demonstrate weight reductions of 15-21% — the most effective pharmacological weight loss data ever published. These results are attributed to the dual receptor mechanism.
Blood Sugar Regulation: Tirzepatide improves insulin sensitivity and glucose regulation, with research applications extending beyond weight management to metabolic syndrome and type 2 diabetes research.
ORYN Format: €169 for a 30-day pen containing 10mg of pharmaceutical-grade Tirzepatide. Also available as a MediT Pen (40mg, €249) for weekly dosing.
Choosing Between Ipamorelin and Tirzepatide
These peptides serve entirely different research purposes:
Choose Ipamorelin if: - Your research focuses on growth hormone biology - Body composition via GH/IGF-1 pathways is the endpoint - Sleep quality and recovery are key research variables - You need the cleanest, most selective GH stimulation available - Budget is a consideration (€109 vs €169)
Choose Tirzepatide if: - Metabolic research is your primary focus - Weight management and appetite regulation are key endpoints - Blood sugar regulation and insulin sensitivity are relevant - You want the most clinically validated weight loss compound available - Your protocol aligns with incretin biology
Can they be combined? Whilst there is limited published research on this specific combination, the mechanisms are non-overlapping. Some researchers study them together when investigating the intersection of GH biology and metabolic regulation.
